Lewes, DE -- (SBWIRE) -- 09/12/2013 -- LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community. Out Today’s Focus is on: X-Change Corp(OTCMKTS:XCHC), NITTO DENKO ADR(OTCMKTS:NDEKY), Cellceutix Corp(OTCBB:CTIX), GUYANA GOLDFIELD NEW(OTCMKTS:GUYFF).
X-Change Corp(OTCMKTS:XCHC) ended lower -7.58% and complete the day at $0.0305. The total number of shares changed hands during the day was 5.09 million. After opening at $0.03, the stock hit as high as $0.03. However, it traded between $0.03 and $0.25 over the last twelve months.
The X-Change Corporation offers nutraceuticals and cosmetics in the United States. It provides lip balms, eczema moisturizing cream, sunscreen, and anti-ageing serum under the Phytiva brand name. The company was incorporated in 1969 and is based in Dallas, Texas.
Has XCHC Found The Bottom and Ready To Move Up? Find Out Here
NITTO DENKO ADR(OTCMKTS:NDEKY) closed yesterday at $31.03, a -2.70% decrease. Around 95,077 shares were traded, beating an-average trading volume of 19,289 shares. The company is now valued at around $11.08 billion.
Nitto Denko Corporation provides optical films, automotive materials and parts, reverse osmosis membranes, and transdermal drug delivery patches. It offers electronics-related products, such as optical films, flexible printed circuits, thin-film metal circuit boards, and semiconductor encapsulating resins used in liquid crystal display televisions, personal computers, cell phones, handheld game consoles, portable audio players, and hard disk drives.
Has NDEKY Found The Bottom And Ready To Gain Momentum? Find Out Here
Cellceutix Corp(OTCBB:CTIX) moved -0.51 percent lower at $1.97 and traded between $1.96 and $2.02 after opening the day at $1.98. Its performance over the last five days remained 3.14%, which stands at 1.55% for a month. Going back further than one month, 1-year performance after recent close was 7.65%.
Cellceutix Corporation, a development stage biopharmaceutical company, engages in the discovery and development of small molecule drugs to treat diseases primarily in the areas of cancer and inflammatory disease
Why Should Investors Buy CTIX After the Recent Fall? Just Go Here and Find Out
GUYANA GOLDFIELD NEW(OTCMKTS:GUYFF) shares fall, losing -4.55 percent to close at $2.15. The stock is down around -31.82% this year and -32.35% for the last 12 months. Around 91,000 shares changed hands yesterday, higher from an-average trading volume of 69,805 shares.
Guyana Goldfields Inc. engages in the acquisition, exploration, evaluation, and development of gold resource properties in Guyana. The company owns a 100% interest in the Aurora gold project located in Guyana. It also holds interests in Aranka properties, which cover an area of approximately 216,888 acres located in the Aranka district of Guyana. Guyana Goldfields Inc. is headquartered in Toronto, Canada
Will GUYFF Get Buyers Even After The Recent Rally? Find Out Here
LeadingStockAlerts is a financial marketing firm that specializes in assisting the underserved small cap and micro-cap stock community.
Our site has been the clear choice for today’s investors and day-traders. As one of the internet’s premiere financial destinations, we offer the investment community some of the market’s leading emerging opportunities. Using a balanced combination of industry experience and high-tech offerings, this site keeps you ahead of the curve and ahead of the bell.
DO NOT BASE ANY INVESTMENT DECISION UPON ANY MATERIALS FOUND ON THIS REPORT OR WEBSITE. We are not registered as a securities broker-dealer or an investment adviser either with the U.S. Securities and Exchange Commission (the “SEC”) or with any state securities regulatory authority. We are neither licensed nor qualified to provide investment advice.
The information contained in our report should be viewed as commercial advertisement and is not intended to be investment advice. The report is not provided to any particular individual with a view toward their individual circumstances. The information contained in our report is not an offer to buy or sell securities. We distribute opinions, comments and information free of charge exclusively to individuals who wish to receive them.
Read Full Disclaimer at: http://leadingstockalerts.com/disclaimer/